Cargando…
Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma
The oncogenic Kaposi's sarcoma–associated herpesvirus (KSHV) is a principal causative agent of primary effusion lymphoma (PEL), which is mostly seen in immunosuppressed patients. PEL is a rapidly progressing malignancy with a median survival time of approximately 6 months even under the convent...
Autores principales: | Lam, Bao Quoc, Dai, Lu, Li, Li, Qiao, Jing, Lin, Zhen, Qin, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392335/ https://www.ncbi.nlm.nih.gov/pubmed/28407694 http://dx.doi.org/10.18632/oncotarget.15444 |
Ejemplares similares
-
Genomic analysis of xCT-regulatory network in KSHV + primary effusion lymphomas
por: Qin, Zhiqiang, et al.
Publicado: (2016) -
The role of HGF/c-MET signaling pathway in lymphoma
por: Lam, Bao Quoc, et al.
Publicado: (2016) -
Systematic Analysis of a Xenograft Mice Model for KSHV(+) Primary Effusion Lymphoma (PEL)
por: Dai, Lu, et al.
Publicado: (2014) -
Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition
por: Li, Xiaojuan, et al.
Publicado: (2023) -
Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors
por: Tolani, Bhairavi, et al.
Publicado: (2013)